Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study
No adverse outcomes were observed in mothers or infants at any stage of maternal SARS-CoV-2 infection. Antibodies in umbilical cord blood and breast milk may offer passive immunity to newborns for 1-3 months. Reinfection during pregnancy may extend this immunity without raising the risk of adverse outcomes.
Authors
- Yang Sun (ORCID: https://orcid.org/0000-0003-1425-0089)
- Liyan Wang (ORCID: https://orcid.org/0000-0002-6564-1090)
- Mingfang Zhou
- Yan Li (ORCID: https://orcid.org/0000-0002-9402-1093)
- N Chen
- Ping Yi (ORCID: https://orcid.org/0000-0002-4055-0459)
- Xia Li (ORCID: https://orcid.org/0000-0001-7765-0333)
- Xin Luo (ORCID: https://orcid.org/0000-0002-4592-6734)
- Hu Shan (ORCID: https://orcid.org/0000-0001-6032-1496)
- Zailin Yang (ORCID: https://orcid.org/0000-0002-8587-975X)
- Liqiang Xie (ORCID: https://orcid.org/0000-0002-7437-5708)
- Jing Xu (ORCID: https://orcid.org/0000-0002-8000-2510)
Institutions
- Chongqing University (CN)
- Chongqing Cancer Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- BMC Pregnancy and Childbirth
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1186/s12884-025-07323-7
- Citations
- 1
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 2.06